China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China flag China · Delayed Price · Currency is CNY
17.72
+0.15 (0.85%)
Apr 29, 2026, 3:04 PM CST

China Resources Boya Bio-pharmaceutical Group Co.,Ltd Company Description

China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the research, development, production, and sale of blood products in China.

It offers blood products, such as human serum albumin; human, intravenous, freeze-dried intravenous, hepatitis B, tetanus, and rabies immunoglobulin; and human fibrinogen, prothrombin complex, and coagulation factor VIII.

The company also provides compound bone peptide, oxytocin, heparin sodium injection, posterior pituitary, and carboprost tromethamine injection.

In addition, it engages in research, development, production, and sales of anti-infective, diabetes, and cardiovascular drugs.

The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co.,Ltd. The company was founded in 1993 and is based in Fuzhou, China.

China Resources Boya Bio-pharmaceutical Group Co.,Ltd
Country China
Founded 1993
Industry Biotechnology
Sector Healthcare
Employees 1,947
CEO Xiaoming Liang

Contact Details

Address:
No. 333, Huiquan Road
Fuzhou, 344000
China
Phone 86 79 4822 4549
Website china-boya.com

Stock Details

Ticker Symbol 300294
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100001FF1
SIC Code 2836

Key Executives

Name Position
Yuxuan Pan Chief Financial Officer, Board Secretary and Director
Shousun Ii Vice President
Shuanhong Zhang Vice President
Zi He Wang Accounting Supervisor
Qingsong Lin Vice President